BostonGene uses its state-of-the-art molecular testing laboratory to combine next-generation sequencing technologies. It integrates whole-exome sequencing, whole-transcriptome sequencing, multiplex immunofluorescence imaging, flow cytometry, bioinformatics, and analytics to produce comprehensive reports on the unique molecular portraits of tumors. This report equips doctors with all relevant information to identify personalized treatment plans.
Samples are processed at the BostonGene laboratory. The laboratory is CLIA and CAP accredited for DNA and RNA sequencing: